To evaluate ECA's current status and to further develop the organisation as the leading European information and training services provider in the field of GMP and pharmaceutical Quality Assurance, the European Compliance Academy's (ECA) Advisory Board meets on an annual basis. All members representing the pharmaceutical industry as well as regulatory authorities attended the meeting that took place in Heidelberg's Technology Park on 27 June, following the successful 2nd European GMP Conference (we will report in one of the next newsletters).
 
"As in the past years we have been experiencing again a lot of support from all members of the Advisory Board." said Daniel Scheidegger, ECA's Chairman. "The tremendous success we had with the new interest groups is a good demonstration for the productive teamwork."
 

The photo shows from left to right:
Richard Bonner, UK; Dr Robert Johnson, Chairman Rapid Microbiological Methods (RMM) Working Group, Dialogue, Switzerland; Colin Booth, Oxoid, UK; Daniel Scheidegger, Chairman of the ECA Advisory Board, Genzyme Pharmaceuticals, Switzerland; Dr Bernd Renger, Chairman of the European QP Association, Vetter Pharma-Fertigung, Germany; Dr Ludwig Huber, Agilent Technologies, Germany; Dr Boris Pimentel, DSM Nutritional Products, Switzerland; Matt Moran, PharmaChemical Ireland, Ireland; Dr Wolfgang Schumacher, F. Hoffmann-La Roche, Switzerland.
  

 
Author:
Wolfgang Heimes
On behalf of the European Compliance Academy (ECA)